Position in NBIX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$646,856
+$220,678 QoQ
Shares Held
3,838
+18.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#65
of 185 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Diversified Trust Co holds $7,361,298 across 10 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
54,538 | $2,857,518 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,216 | $1,200,695 | |
| 3 | VTRS |
Viatris Inc
|
56,808 | $902,111 | |
| 4 | ZTS |
Zoetis Inc.
|
9,027 | $648,680 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
3,838 | $646,856 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
17,060 | $295,308 | |
| 7 | HLN |
Haleon plc
|
30,794 | $287,308 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
32,062 | $253,931 |
All Filings in NBIX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $646,856 | 3,838 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $426,178 | 3,235 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $456,692 | 3,220 | Shares | Sole | 2026-01-09 | |
| 2023-12-31 | $313,720 | 2,381 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $237,825 | 2,114 | Shares | Sole | 2023-11-17 | |
| 2023-03-31 | $234,425 | 2,316 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $259,543 | 2,173 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $237,591 | 2,237 | Shares | Sole | 2022-10-14 | |
| No filing history on record for this holder in this stock. | ||||||